-
2
-
-
84928898387
-
Pathobiology of liver fibrosis: A translational success story
-
gutjnl-2014-306842 [Epub ahead of print]
-
Y.A. Lee, M.C. Wallace, and S.L. Friedman Pathobiology of liver fibrosis: a translational success story Gut 2015 http://dx.doi.org/10.1136/gutjnl-2014-306842, pii: gutjnl-2014-306842 [Epub ahead of print]
-
(2015)
Gut
-
-
Lee, Y.A.1
Wallace, M.C.2
Friedman, S.L.3
-
4
-
-
33847350691
-
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
-
T.A. Wynn Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases J Clin Invest 117 2007 524 529
-
(2007)
J Clin Invest
, vol.117
, pp. 524-529
-
-
Wynn, T.A.1
-
5
-
-
0019230284
-
Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and Vitamin A-storing cells in extrahepatic organs
-
K. Wake Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs Int Rev Cytol 66 1980 303 353
-
(1980)
Int Rev Cytol
, vol.66
, pp. 303-353
-
-
Wake, K.1
-
6
-
-
35948958955
-
TLR4 enhances TGF-beta signaling and hepatic fibrosis
-
E. Seki, S. De Minicis, C.H. Osterreicher, J. Kluwe, Y. Osawa, D.A. Brenner, and et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis Nat Med 13 2007 1324 1332
-
(2007)
Nat Med
, vol.13
, pp. 1324-1332
-
-
Seki, E.1
De Minicis, S.2
Osterreicher, C.H.3
Kluwe, J.4
Osawa, Y.5
Brenner, D.A.6
-
7
-
-
84896754721
-
Transcriptional repression of the transforming growth factor β (TGF-β) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor κb (NF-κB) p50 enhances TGF-β signaling in hepatic stellate cells
-
C. Liu, X. Chen, L. Yang, T. Kisseleva, D.A. Brenner, and E. Seki Transcriptional repression of the transforming growth factor β (TGF-β) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor κB (NF-κB) p50 enhances TGF-β signaling in hepatic stellate cells J Biol Chem 289 2014 7082 7091
-
(2014)
J Biol Chem
, vol.289
, pp. 7082-7091
-
-
Liu, C.1
Chen, X.2
Yang, L.3
Kisseleva, T.4
Brenner, D.A.5
Seki, E.6
-
8
-
-
69949160564
-
Redox mechanisms in hepatic chronic wound healing and fibrogenesis
-
E. Novo, and M. Parola Redox mechanisms in hepatic chronic wound healing and fibrogenesis Fibrogenesis Tissue Repair 1 2008 5
-
(2008)
Fibrogenesis Tissue Repair
, vol.1
, pp. 5
-
-
Novo, E.1
Parola, M.2
-
9
-
-
40849083460
-
Non-alcoholic fatty liver: The mist gradually clear
-
N.M.W. De Alwis, and C.P. Day Non-alcoholic fatty liver: the mist gradually clear J Hepatol 48 2008 S105 S112
-
(2008)
J Hepatol
, vol.48
, pp. S105-S112
-
-
De Alwis, N.M.W.1
Day, C.P.2
-
12
-
-
84857055199
-
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
-
C. Baeck, A. Wehr, K.R. Karlmark, F. Heymann, M. Vucur, N. Gassler, and et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury Gut 61 2012 416 426
-
(2012)
Gut
, vol.61
, pp. 416-426
-
-
Baeck, C.1
Wehr, A.2
Karlmark, K.R.3
Heymann, F.4
Vucur, M.5
Gassler, N.6
-
13
-
-
84906535982
-
Roles for chemokines in liver disease
-
F. Marra, and F. Tacke Roles for chemokines in liver disease Gastroenterology 147 2014 577 594
-
(2014)
Gastroenterology
, vol.147
, pp. 577-594
-
-
Marra, F.1
Tacke, F.2
-
14
-
-
84898789996
-
Macrophage heterogeneity in liver injury and fibrosis
-
F. Tacke, and H.W. Zimmermann Macrophage heterogeneity in liver injury and fibrosis J Hepatol 60 2014 1090 1096
-
(2014)
J Hepatol
, vol.60
, pp. 1090-1096
-
-
Tacke, F.1
Zimmermann, H.W.2
-
15
-
-
24044432235
-
Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells
-
P. Brun, I. Castagliuolo, M. Pinzani, G. Palu, and D. Martines Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells Am J Physiol Gastrointest Liver Physiol 289 2005 G571 G578
-
(2005)
Am J Physiol Gastrointest Liver Physiol
, vol.289
, pp. G571-G578
-
-
Brun, P.1
Castagliuolo, I.2
Pinzani, M.3
Palu, G.4
Martines, D.5
-
16
-
-
84898824175
-
Interactions between the intestinal microbiome and liver diseases
-
B. Schnabl, and D.A. Brenner Interactions between the intestinal microbiome and liver diseases Gastroenterology 146 2014 1513 1524
-
(2014)
Gastroenterology
, vol.146
, pp. 1513-1524
-
-
Schnabl, B.1
Brenner, D.A.2
-
17
-
-
34447317835
-
Vascular endothelial growth factor and angiopoietin-1 as hypoxia-dependent autocrine and paracrine factors stimulating migration and chemotaxis of activated human hepatic stellate cells
-
E. Novo, S. Cannito, E. Zamara, L. Valfrè di Bonzo, A. Caligiuri, C. Cravanzola, and et al. Vascular endothelial growth factor and angiopoietin-1 as hypoxia-dependent autocrine and paracrine factors stimulating migration and chemotaxis of activated human hepatic stellate cells Am J Pathol 170 2007 1942 1953
-
(2007)
Am J Pathol
, vol.170
, pp. 1942-1953
-
-
Novo, E.1
Cannito, S.2
Zamara, E.3
Valfrè Di Bonzo, L.4
Caligiuri, A.5
Cravanzola, C.6
-
18
-
-
84868102616
-
Hedgehog controls hepatic stellate cell fate by regulating metabolism
-
Y. Chen, S.S. Choi, G.A. Michelotti, I.S. Chan, M. Swiderska-Syn, G.F. Karaca, and et al. Hedgehog controls hepatic stellate cell fate by regulating metabolism Gastroenterology 143 2012 1319 1329
-
(2012)
Gastroenterology
, vol.143
, pp. 1319-1329
-
-
Chen, Y.1
Choi, S.S.2
Michelotti, G.A.3
Chan, I.S.4
Swiderska-Syn, M.5
Karaca, G.F.6
-
19
-
-
84904795250
-
Epigenetics in liver disease
-
D.A. Mann Epigenetics in liver disease Hepatology 60 2014 1418 1425
-
(2014)
Hepatology
, vol.60
, pp. 1418-1425
-
-
Mann, D.A.1
-
20
-
-
79959893918
-
Hepatic stellate cells require a stiff environment for myofibroblastic differentiation
-
A.L. Olsen, S.A. Bloomer, E.P. Chan, M.D. Gaça, P.C. Georges, B. Sackey, and et al. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation Am J Physiol Gastrointest Liver Physiol 301 2011 G110 G118
-
(2011)
Am J Physiol Gastrointest Liver Physiol
, vol.301
, pp. G110-G118
-
-
Olsen, A.L.1
Bloomer, S.A.2
Chan, E.P.3
Gaça, M.D.4
Georges, P.C.5
Sackey, B.6
-
21
-
-
84862195154
-
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
-
T. Kisseleva, M. Cong, Y. Paik, D. Scholten, C. Jiang, C. Benner, and et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis Proc Natl Acad Sci U S A 109 2012 9448 9453
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 9448-9453
-
-
Kisseleva, T.1
Cong, M.2
Paik, Y.3
Scholten, D.4
Jiang, C.5
Benner, C.6
-
22
-
-
0030175327
-
Pyridinoline collagen cross-links in patients with chronic viral hepatitis and cirrhosis
-
A. Hayasaka, S. Ilda, N. Suzuki, F. Kondo, M. Miyazaki, and H. Yonemitsu Pyridinoline collagen cross-links in patients with chronic viral hepatitis and cirrhosis J Hepatol 24 1996 692 698
-
(1996)
J Hepatol
, vol.24
, pp. 692-698
-
-
Hayasaka, A.1
Ilda, S.2
Suzuki, N.3
Kondo, F.4
Miyazaki, M.5
Yonemitsu, H.6
-
23
-
-
2942622398
-
Spontaneous recovery from micronodular cirrhosis: Evidence for incomplete resolution associated with matrix cross-linking
-
R. Issa, X. Zhou, C.M. Constandinou, J. Fallowfield, H. Millward-Sadler, M.D. Gaca, and et al. Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking Gastroenterology 126 2004 1795 1808
-
(2004)
Gastroenterology
, vol.126
, pp. 1795-1808
-
-
Issa, R.1
Zhou, X.2
Constandinou, C.M.3
Fallowfield, J.4
Millward-Sadler, H.5
Gaca, M.D.6
-
24
-
-
33746120376
-
Overexpression of Bcl-2 by activated human hepatic stellate cells: Resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans
-
E. Novo, F. Marra, E. Zamara, L. Valfrè di Bonzo, L. Monitillo, S. Cannito, and et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans Gut 55 2006 1174 1182
-
(2006)
Gut
, vol.55
, pp. 1174-1182
-
-
Novo, E.1
Marra, F.2
Zamara, E.3
Valfrè Di Bonzo, L.4
Monitillo, L.5
Cannito, S.6
-
25
-
-
77956425361
-
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
-
V. Barry-Hamilton, R. Spangler, D. Marshall, S. McCauley, H.M. Rodriguez, M. Oyasu, and et al. Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment Nat Med 16 2010 1009 1017
-
(2010)
Nat Med
, vol.16
, pp. 1009-1017
-
-
Barry-Hamilton, V.1
Spangler, R.2
Marshall, D.3
McCauley, S.4
Rodriguez, H.M.5
Oyasu, M.6
-
26
-
-
84856461322
-
Antifibrotic therapy: Lost in translation?
-
D. Schuppan, and M. Pinzani Antifibrotic therapy: lost in translation? J Hepatol 56 2012 S66 S74
-
(2012)
J Hepatol
, vol.56
, pp. S66-S74
-
-
Schuppan, D.1
Pinzani, M.2
-
27
-
-
84877141184
-
Evolving therapies for liver fibrosis
-
D. Schuppan, and Y.O. Kim Evolving therapies for liver fibrosis J Clin Invest 123 2013 1887 1901
-
(2013)
J Clin Invest
, vol.123
, pp. 1887-1901
-
-
Schuppan, D.1
Kim, Y.O.2
-
28
-
-
84947121337
-
Antifibrotic therapies: Moving towards clinical translation
-
Mehal WZ, Schuppan D. Antifibrotic therapies: Moving towards clinical translation. Semin Liver Dis 2015.
-
(2015)
Semin Liver Dis
-
-
Mehal, W.Z.1
Schuppan, D.2
-
29
-
-
84873726484
-
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: A 5-year open-label follow-up study
-
P. Marcellin, E. Gane, M. Buti, N. Afdhal, W. Sievert, I.M. Jacobson, and et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Lancet 381 2013 468 475
-
(2013)
Lancet
, vol.381
, pp. 468-475
-
-
Marcellin, P.1
Gane, E.2
Buti, M.3
Afdhal, N.4
Sievert, W.5
Jacobson, I.M.6
-
30
-
-
84864367149
-
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
-
R. D'Ambrosio, A. Aghemo, M.G. Rumi, G. Ronchi, M.F. Donato, V. Paradis, and et al. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis Hepatology 56 2012 532 543
-
(2012)
Hepatology
, vol.56
, pp. 532-543
-
-
D'Ambrosio, R.1
Aghemo, A.2
Rumi, M.G.3
Ronchi, G.4
Donato, M.F.5
Paradis, V.6
-
31
-
-
77950201652
-
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection
-
J. McHutchison, Z. Goodman, K. Patel, H. Makhlouf, M. Rodriguez-Torres, M. Shiffman, and et al. Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection Gastroenterology 138 2010 1365 1373
-
(2010)
Gastroenterology
, vol.138
, pp. 1365-1373
-
-
McHutchison, J.1
Goodman, Z.2
Patel, K.3
Makhlouf, H.4
Rodriguez-Torres, M.5
Shiffman, M.6
-
32
-
-
84939941663
-
Toward an integrated pipeline for protein biomarker development
-
S1570-9639(14)00229-5 [Epub ahead of print]
-
A.P. Drabovich, E. Martínez-Morillo, and E.P. Diamandis Toward an integrated pipeline for protein biomarker development Biochim Biophys Acta 2014 http://dx.doi.org/10.1016/j.bbapap.2014.09.006, pii: S1570-9639(14)00229-5 [Epub ahead of print]
-
(2014)
Biochim Biophys Acta
-
-
Drabovich, A.P.1
Martínez-Morillo, E.2
Diamandis, E.P.3
-
33
-
-
40049097359
-
Liver cirrhosis
-
D. Schuppan, and N.H. Afdhal Liver cirrhosis Lancet 371 2008 838 851
-
(2008)
Lancet
, vol.371
, pp. 838-851
-
-
Schuppan, D.1
Afdhal, N.H.2
-
34
-
-
70350077449
-
Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies
-
Y. Popov, and D. Schuppan Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies Hepatology 50 2009 1294 1306
-
(2009)
Hepatology
, vol.50
, pp. 1294-1306
-
-
Popov, Y.1
Schuppan, D.2
-
35
-
-
84860299294
-
Noninvasive methods to assess liver disease in patients with hepatitis B or C
-
L. Castera Noninvasive methods to assess liver disease in patients with hepatitis B or C Gastroenterology 142 2012 1293 1302
-
(2012)
Gastroenterology
, vol.142
, pp. 1293-1302
-
-
Castera, L.1
-
36
-
-
84918578495
-
Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
-
T.G. Simon, L.Y. King, H. Zheng, and R.T. Chung Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C J Hepatol 62 2015 18 23
-
(2015)
J Hepatol
, vol.62
, pp. 18-23
-
-
Simon, T.G.1
King, L.Y.2
Zheng, H.3
Chung, R.T.4
-
37
-
-
84913580343
-
Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice
-
S. Yoshida, N. Ikenaga, S.B. Liu, Z.W. Peng, J. Chung, D.Y. Sverdlov, and et al. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice Gastroenterology 147 2014 1378 1392
-
(2014)
Gastroenterology
, vol.147
, pp. 1378-1392
-
-
Yoshida, S.1
Ikenaga, N.2
Liu, S.B.3
Peng, Z.W.4
Chung, J.5
Sverdlov, D.Y.6
-
38
-
-
34247619364
-
Gene expression profiles during hepatic stellate cell activation in culture and in vivo
-
S. De Minicis, E. Seki, H. Uchinami, J. Kluwe, Y. Zhang, D.A. Brenner, and et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo Gastroenterology 132 2007 1937 1946
-
(2007)
Gastroenterology
, vol.132
, pp. 1937-1946
-
-
De Minicis, S.1
Seki, E.2
Uchinami, H.3
Kluwe, J.4
Zhang, Y.5
Brenner, D.A.6
-
39
-
-
77956123956
-
Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture
-
P.M. Gilbert, K.L. Havenstrite, K.E. Magnusson, and et al. Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture Science 329 2010 1078 1081
-
(2010)
Science
, vol.329
, pp. 1078-1081
-
-
Gilbert, P.M.1
Havenstrite, K.L.2
Magnusson, K.E.3
-
40
-
-
67650710740
-
The elastic modulus of Matrigel™ as determined by atomic force microscopy
-
S.S. Soofi, J.A. Last, S.J. Liliensiek, and et al. The elastic modulus of Matrigel™ as determined by atomic force microscopy J Struct Biol 167 2009 216 219
-
(2009)
J Struct Biol
, vol.167
, pp. 216-219
-
-
Soofi, S.S.1
Last, J.A.2
Liliensiek, S.J.3
-
41
-
-
29144531874
-
Mechanobiology in the third dimension
-
J.A. Pedersen, and M.A. Swartz Mechanobiology in the third dimension Ann Biomed Eng 33 2005 1469 1490
-
(2005)
Ann Biomed Eng
, vol.33
, pp. 1469-1490
-
-
Pedersen, J.A.1
Swartz, M.A.2
-
42
-
-
84887035390
-
Fibroblasts and the ground they walk on
-
D.J. Tschumperlin Fibroblasts and the ground they walk on Physiology (Bethesda) 28 2013 380 390
-
(2013)
Physiology (Bethesda)
, vol.28
, pp. 380-390
-
-
Tschumperlin, D.J.1
-
43
-
-
84883559642
-
In the beginning there were soft collagen-cell gels: Towards better 3D connective tissue models?
-
R.A. Brown In the beginning there were soft collagen-cell gels: towards better 3D connective tissue models? Exp Cell Res 319 2013 2460 2469
-
(2013)
Exp Cell Res
, vol.319
, pp. 2460-2469
-
-
Brown, R.A.1
-
44
-
-
84883552306
-
Fibroblast morphogenesis on 3D collagen matrices: The balance between cell clustering and cell migration
-
B. da Rocha-Azevedo, and F. Grinnell Fibroblast morphogenesis on 3D collagen matrices: the balance between cell clustering and cell migration Exp Cell Res 319 2013 2440 2446
-
(2013)
Exp Cell Res
, vol.319
, pp. 2440-2446
-
-
Da Rocha-Azevedo, B.1
Grinnell, F.2
-
45
-
-
84947054592
-
Decellularized human Liver as a natural 3D scaffold for organ Engineering and 3D-disease modelling
-
[Abstract]
-
G. Mazza, K. Rombouts, A.R. Hall, L. Urbani, L. Longato, A.M. Holmes, and et al. Decellularized human Liver as a natural 3D scaffold for organ Engineering and 3D-disease modelling Hepatology 60 2014 59A [Abstract]
-
(2014)
Hepatology
, vol.60
, pp. 59A
-
-
Mazza, G.1
Rombouts, K.2
Hall, A.R.3
Urbani, L.4
Longato, L.5
Holmes, A.M.6
-
46
-
-
27744512904
-
Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes
-
Y. Popov, E. Patsenker, P. Fickert, M. Trauner, and D. Schuppan Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes J Hepatol 43 2005 1045 1054
-
(2005)
J Hepatol
, vol.43
, pp. 1045-1054
-
-
Popov, Y.1
Patsenker, E.2
Fickert, P.3
Trauner, M.4
Schuppan, D.5
-
47
-
-
79955450436
-
Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice
-
Y. Popov, D.Y. Sverdlov, A.K. Sharma, K.R. Bhaskar, S. Li, T.L. Freitag, and et al. Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice Gastroenterology 140 2011 1642 1652
-
(2011)
Gastroenterology
, vol.140
, pp. 1642-1652
-
-
Popov, Y.1
Sverdlov, D.Y.2
Sharma, A.K.3
Bhaskar, K.R.4
Li, S.5
Freitag, T.L.6
-
48
-
-
0038374866
-
Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis
-
E. Ueberham, R. Low, U. Ueberham, K. Schönig, H. Bujard, R. Gebhardt, and et al. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis Hepatology 37 2003 1067 1078
-
(2003)
Hepatology
, vol.37
, pp. 1067-1078
-
-
Ueberham, E.1
Low, R.2
Ueberham, U.3
Schönig, K.4
Bujard, H.5
Gebhardt, R.6
-
49
-
-
33746561298
-
Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice
-
P. Czochra, B. Klopcic, E. Meyer, J. Herkel, J.F. Garcia-Lazaro, F. Thieringer, and et al. Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice J Hepatol 45 2006 419 428
-
(2006)
J Hepatol
, vol.45
, pp. 419-428
-
-
Czochra, P.1
Klopcic, B.2
Meyer, E.3
Herkel, J.4
Garcia-Lazaro, J.F.5
Thieringer, F.6
-
50
-
-
20044385758
-
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma
-
J.S. Campbell, S.D. Hughes, D.G. Gilbertson, T.E. Palmer, M.S. Holdren, A.C. Haran, and et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma Proc Natl Acad Sci USA 102 2005 3389 3394
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 3389-3394
-
-
Campbell, J.S.1
Hughes, S.D.2
Gilbertson, D.G.3
Palmer, T.E.4
Holdren, M.S.5
Haran, A.C.6
-
51
-
-
84877920627
-
Precision-cut liver slices: A tool to model the liver ex vivo
-
P. Olinga, and D. Schuppan Precision-cut liver slices: a tool to model the liver ex vivo J Hepatol 58 2013 1252 1253
-
(2013)
J Hepatol
, vol.58
, pp. 1252-1253
-
-
Olinga, P.1
Schuppan, D.2
-
52
-
-
1342303482
-
Of mice and not men: Differences between mouse and human immunology
-
J. Mestas, and C.C. Hughes Of mice and not men: differences between mouse and human immunology J Immunol 172 2004 2731 2738
-
(2004)
J Immunol
, vol.172
, pp. 2731-2738
-
-
Mestas, J.1
Hughes, C.C.2
-
53
-
-
84902654739
-
Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome
-
Y. Huang, W.B. de Boer, L.A. Adams, G. MacQuillan, M.K. Bulsara, and G.P. Jeffrey Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome J Hepatol 61 2014 22 27
-
(2014)
J Hepatol
, vol.61
, pp. 22-27
-
-
Huang, Y.1
De Boer, W.B.2
Adams, L.A.3
MacQuillan, G.4
Bulsara, M.K.5
Jeffrey, G.P.6
-
54
-
-
77956639159
-
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
-
T.T. Chang, Y.F. Liaw, S.S. Wu, E. Schiff, K.H. Han, C.L. Lai, and et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B Hepatology 52 2010 886 893
-
(2010)
Hepatology
, vol.52
, pp. 886-893
-
-
Chang, T.T.1
Liaw, Y.F.2
Wu, S.S.3
Schiff, E.4
Han, K.H.5
Lai, C.L.6
-
55
-
-
80052027568
-
Liver stiffness diminishes with antiviral response in chronic hepatitis C
-
C. Hezode, L. Castera, F. Roudot-Thoraval, M. Bouvier-Alias, I. Rosa, D. Roulot, and et al. Liver stiffness diminishes with antiviral response in chronic hepatitis C Aliment Pharmacol Ther 34 2011 656 663
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 656-663
-
-
Hezode, C.1
Castera, L.2
Roudot-Thoraval, F.3
Bouvier-Alias, M.4
Rosa, I.5
Roulot, D.6
-
56
-
-
84927798150
-
Effects of bariatric surgery on severe liver injury in morbid obese patients with proven NASH: A prospective study
-
Abstract 213
-
G. Lassailly, R. Caiazzo, D. Buob, M. Pigeyre, H. Verkindt, V. Raverdy, and et al. Effects of bariatric surgery on severe liver injury in morbid obese patients with proven NASH: a prospective study Hepatology 60 2014 Abstract 213
-
(2014)
Hepatology
, vol.60
-
-
Lassailly, G.1
Caiazzo, R.2
Buob, D.3
Pigeyre, M.4
Verkindt, H.5
Raverdy, V.6
-
57
-
-
20344397684
-
Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B
-
P. Liu, Y.Y. Hu, C. Liu, and et al. Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B World J Gastroenterol 11 2005 2892 2899
-
(2005)
World J Gastroenterol
, vol.11
, pp. 2892-2899
-
-
Liu, P.1
Hu, Y.Y.2
Liu, C.3
-
58
-
-
0028294206
-
Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. The
-
R.E. Poupon, R. Poupon, and B. Balkau Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. The N Engl J Med 330 1994 1342 1347
-
(1994)
N Engl J Med
, vol.330
, pp. 1342-1347
-
-
Poupon, R.E.1
Poupon, R.2
Balkau, B.3
-
59
-
-
0033658752
-
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
-
C. Corpechot, F. Carrat, A.M. Bonnand, and et al. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis Hepatology 32 2000 1196 1199
-
(2000)
Hepatology
, vol.32
, pp. 1196-1199
-
-
Corpechot, C.1
Carrat, F.2
Bonnand, A.M.3
-
60
-
-
84862813779
-
Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - A randomized open-label controlled study
-
M.Y. Kim, M.Y. Cho, S.K. Baik, and et al. Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - a randomized open-label controlled study Liver Int 32 2012 977 987
-
(2012)
Liver Int
, vol.32
, pp. 977-987
-
-
Kim, M.Y.1
Cho, M.Y.2
Baik, S.K.3
-
61
-
-
33751545838
-
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
-
R. Belfort, S.A. Harrison, K. Brown, and et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis N Engl J Med 355 2006 2297 2307
-
(2006)
N Engl J Med
, vol.355
, pp. 2297-2307
-
-
Belfort, R.1
Harrison, S.A.2
Brown, K.3
-
62
-
-
53049101877
-
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
-
G.P. Aithal, J.A. Thomas, P.V. Kaye, and et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis Gastroenterology 135 2008 1176 1184
-
(2008)
Gastroenterology
, vol.135
, pp. 1176-1184
-
-
Aithal, G.P.1
Thomas, J.A.2
Kaye, P.V.3
-
63
-
-
77951874018
-
Pioglitazone, Vitamin E, or placebo for nonalcoholic steatohepatitis
-
A.J. Sanyal, N. Chalasani, K.V. Kowdley, and et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 362 2010 1675 1685
-
(2010)
N Engl J Med
, vol.362
, pp. 1675-1685
-
-
Sanyal, A.J.1
Chalasani, N.2
Kowdley, K.V.3
-
64
-
-
75449116707
-
Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
-
V. Ratziu, F. Charlotte, C. Bernhardt, and et al. Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial Hepatology 51 2010 445 453
-
(2010)
Hepatology
, vol.51
, pp. 445-453
-
-
Ratziu, V.1
Charlotte, F.2
Bernhardt, C.3
-
65
-
-
80055028155
-
Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
-
C.O. Zein, L.M. Yerian, P. Gogate, and et al. Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial Hepatology 54 2011 1610 1619
-
(2011)
Hepatology
, vol.54
, pp. 1610-1619
-
-
Zein, C.O.1
Yerian, L.M.2
Gogate, P.3
-
66
-
-
80055031101
-
Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
-
D.M. Torres, F.J. Jones, J.C. Shaw, and et al. Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial Hepatology 54 2011 1631 1639
-
(2011)
Hepatology
, vol.54
, pp. 1631-1639
-
-
Torres, D.M.1
Jones, F.J.2
Shaw, J.C.3
-
67
-
-
79954764140
-
A randomized controlled trial of high-dose ursodeoxycholic acid for nonalcoholic steatohepatitis
-
V. Ratziu, V. de Ledinghen, F. Oberti, and et al. A randomized controlled trial of high-dose ursodeoxycholic acid for nonalcoholic steatohepatitis J Hepatol 54 2011 1011 1019
-
(2011)
J Hepatol
, vol.54
, pp. 1011-1019
-
-
Ratziu, V.1
De Ledinghen, V.2
Oberti, F.3
-
68
-
-
84929266699
-
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial
-
S0140-6736(14)61933-4
-
B.A. Neuschwander-Tetri, R. Loomba, A.J. Sanyal, and et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial Lancet 2014 pii: S0140-6736(14)61933-4
-
(2014)
Lancet
-
-
Neuschwander-Tetri, B.A.1
Loomba, R.2
Sanyal, A.J.3
-
69
-
-
84927797734
-
Real-time shear-wave elastography: Applicability, reliability and accuracy for clinically significant portal hypertension
-
S0168-8278(14)00925-8
-
B. Procopet, A. Berzigotti, J.G. Abraldes, F. Turon, V. Hernandez-Gea, J.C. García-Pagán, and J. Bosch Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension J Hepatol 2014 10.1016/j.jhep.2014. 12. 007 pii: S0168-8278(14)00925-8
-
(2014)
J Hepatol
-
-
Procopet, B.1
Berzigotti, A.2
Abraldes, J.G.3
Turon, F.4
Hernandez-Gea, V.5
García-Pagán, J.C.6
Bosch, J.7
-
70
-
-
84898807026
-
Role of magnetic resonance elastography in compensated and decompensated liver disease
-
S.K. Asrani, J.A. Talwalkar, P.S. Kamath, V.H. Shah, G. Saracino, L. Jennings, and et al. Role of magnetic resonance elastography in compensated and decompensated liver disease J Hepatol 60 2014 934 939
-
(2014)
J Hepatol
, vol.60
, pp. 934-939
-
-
Asrani, S.K.1
Talwalkar, J.A.2
Kamath, P.S.3
Shah, V.H.4
Saracino, G.5
Jennings, L.6
-
71
-
-
79952467377
-
The mean values of liver stiffness assessed by Acoustic Radiation Force Impulse elastography in normal subjects
-
A. Popescu, I. Sporea, R. Sirli, S. Bota, M. Focsa, M. Danila, and et al. The mean values of liver stiffness assessed by Acoustic Radiation Force Impulse elastography in normal subjects Med Ultrason 13 2011 33 37
-
(2011)
Med Ultrason
, vol.13
, pp. 33-37
-
-
Popescu, A.1
Sporea, I.2
Sirli, R.3
Bota, S.4
Focsa, M.5
Danila, M.6
-
72
-
-
84890569059
-
Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
-
R. Banerjee, M. Pavlides, E.M. Tunnicliffe, S.K. Piechnik, N. Sarania, R. Philips, and et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease J Hepatol 60 2014 69 77
-
(2014)
J Hepatol
, vol.60
, pp. 69-77
-
-
Banerjee, R.1
Pavlides, M.2
Tunnicliffe, E.M.3
Piechnik, S.K.4
Sarania, N.5
Philips, R.6
-
73
-
-
84885951993
-
Molecular MRI of collagen to diagnose and stage liver fibrosis
-
B.C. Fuchs, H. Wang, Y. Yang, L. Wei, M. Polasek, D.T. Schuhle, and et al. Molecular MRI of collagen to diagnose and stage liver fibrosis J Hepatol 59 2013 992 998
-
(2013)
J Hepatol
, vol.59
, pp. 992-998
-
-
Fuchs, B.C.1
Wang, H.2
Yang, Y.3
Wei, L.4
Polasek, M.5
Schuhle, D.T.6
-
74
-
-
34447540249
-
Measurement of liver collagen synthesis by heavy water labeling: Effects of profibrotic toxicants and antifibrotic interventions
-
J.L. Gardner, S.M. Turner, A. Bautista, G. Lindwall, M. Awada, and M.K. Hellerstein Measurement of liver collagen synthesis by heavy water labeling: effects of profibrotic toxicants and antifibrotic interventions Am J Physiol Gastrointest Liver Physiol 292 2007 G1695 G1705
-
(2007)
Am J Physiol Gastrointest Liver Physiol
, vol.292
, pp. G1695-G1705
-
-
Gardner, J.L.1
Turner, S.M.2
Bautista, A.3
Lindwall, G.4
Awada, M.5
Hellerstein, M.K.6
-
75
-
-
84859164941
-
Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial
-
G.T. Everson, M.L. Shiffman, J.C. Hoefs, T.R. Morgan, R.K. Sterling, D.A. Wagner, and et al. Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial Hepatology 55 2012 1019 1029
-
(2012)
Hepatology
, vol.55
, pp. 1019-1029
-
-
Everson, G.T.1
Shiffman, M.L.2
Hoefs, J.C.3
Morgan, T.R.4
Sterling, R.K.5
Wagner, D.A.6
-
76
-
-
52149083035
-
A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT
-
G. Lalazar, O. Pappo, T. Hershcovici, T. Hadjaj, M. Shubi, H. Ohana, and et al. A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT J Viral Hepat 15 2008 716 728
-
(2008)
J Viral Hepat
, vol.15
, pp. 716-728
-
-
Lalazar, G.1
Pappo, O.2
Hershcovici, T.3
Hadjaj, T.4
Shubi, M.5
Ohana, H.6
-
77
-
-
84904857264
-
Accelerating drug development through collaboration: The hepatitis C drug development advisory group
-
C. Hutchison, A. Kwong, S. Ray, K. Struble, T. Swan, and V. Miller Accelerating drug development through collaboration: the hepatitis C drug development advisory group Clin Pharmacol Ther 96 2014 162 165
-
(2014)
Clin Pharmacol Ther
, vol.96
, pp. 162-165
-
-
Hutchison, C.1
Kwong, A.2
Ray, S.3
Struble, K.4
Swan, T.5
Miller, V.6
-
78
-
-
84878930738
-
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
-
Q.M. Anstee, G. Targher, and C.P. Day Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis Nat Rev Gastroenterol Hepatol 10 2013 330 344
-
(2013)
Nat Rev Gastroenterol Hepatol
, vol.10
, pp. 330-344
-
-
Anstee, Q.M.1
Targher, G.2
Day, C.P.3
-
79
-
-
34547539830
-
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis
-
C. Ripoll, R. Groszmann, G. Garcia-Tsao, N. Grace, A. Burroughs, R. Planas, and et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis Gastroenterology 133 2007 481 488
-
(2007)
Gastroenterology
, vol.133
, pp. 481-488
-
-
Ripoll, C.1
Groszmann, R.2
Garcia-Tsao, G.3
Grace, N.4
Burroughs, A.5
Planas, R.6
-
80
-
-
84899409476
-
A histologic scoring system for prognosis of patients with alcoholic hepatitis
-
J. Altamirano, R. Miquel, A. Katoonizadeh, J.G. Abraldes, A. Duarte-Rojo, A. Louvet, and et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis Gastroenterology 146 2014 e1231 e1236
-
(2014)
Gastroenterology
, vol.146
, pp. e1231-e1236
-
-
Altamirano, J.1
Miquel, R.2
Katoonizadeh, A.3
Abraldes, J.G.4
Duarte-Rojo, A.5
Louvet, A.6
|